从广泛的冠状病毒抗病毒药物发现中吸取的教训
Andrew A Bolinger1, Jun Li1, Xuping Xie2,3
1Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA.
Expert opinion on drug discovery
|July 30, 2024
概括
开发广泛的抗病毒药物对于对抗高致病性冠状病毒 (CoV),如SARS-CoV,MERS-CoV和SARS-CoV-2至关重要. 这种方法增强了对未来病毒威胁的公共卫生弹性.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 高致病性冠状病毒 (CoV) 已经造成了重大的全球健康危机,包括COVID-19大流行.
- 这些病毒表现出不同的临床表现,从无症状病例到严重急性呼吸困扰综合征 (ARDS),导致高死亡率.
研究的目的:
- 讨论开发针对冠状病毒的广泛抗病毒药物的策略.
- 突出从最近的抗病毒研究中流行病驱动的进展中吸取的经验教训.
主要方法:
- 审查针对病毒非结构性和结构性蛋白质的策略.
- 探索用于Cov治疗的药物重用和组合疗法方法.
主要成果:
- 在抗病毒药物发现方面已经观察到加速的进展.
- 该研究确定了开发有效的广泛治疗的关键领域.
结论:
- 缺乏广泛的抗病毒药物使公共卫生系统易受新型冠状病毒疫情的影响.
- 优先开发广泛的抗病毒药物对于未来的流行病防控和应对是必不可少的.
相关概念视频
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Structure-Activity Relationships and Drug Design
689
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
689


